Vaccine Promising for Multiple Cancer Indications

Sellas Life Sciences announced top-line data from the Phase 2 clinical study of its WT1 cancer vaccine in patients with malignant pleural mesothelioma (MPM).

Blod Test for Cancer Relapse Promising

An experimental blood test may one day detect the return of early-stage breast cancer months before it is revealed by computed tomography or magnetic resonance imaging.

Odomzo Approved for Advanced Skin Cancer

The FDA has approved Odomzo (sonidegib) capsules for the treatment of adults with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

Cancer Patients Need Fertility Preservation Awareness

Many young cancer patients have limited awareness about options to preserve their fertility.

ED Drugs and Melanoma Risk

Patients taking medications for erectile dysfunction (ED) may have an increased risk of melanoma but these drugs are not a cause of melanoma.

Chili Pepper Toxin, Gallbladder Cancer Risk

Gallbladder cancer seems to be associated with aflatoxin, according to a new study.

No Link Between PTSD, Cancer

While the potential relationship between stress and cancer has been a topic of discussion and research for over 70 years, no association between post-traumatic stress disorder (PTSD) and cancer was found in the largest study to date.

Cyramza Gains Colon Cancer Indication

The FDA has expanded the indication of Cyramza (ramucirumab; Eli Lilly) for use in combination with irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed on a first line bevacizumab-, oxaliplatin- and fluoropyrimidine-containing regimen.

News

Teva Launches Generic Taxotere Injection

Teva Launches Generic Taxotere Injection

Teva announced the launch of Docetaxel Injection, the generic version of Taxotere Injection Concentrate.

How is BRCA Testing Effecting Breast Cancer Tx Decisions?

How is BRCA Testing Effecting Breast Cancer Tx Decisions?

Among young women with breast cancer, the rates of BRCA mutation testing are increasing, according to research published online February 11 in JAMA Oncology.

Updated Biomarker Recommendations for Breast Cancer Tx

Updated Biomarker Recommendations for Breast Cancer Tx

The American Society of Clinical Oncology has updated recommendations on the use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer. The clinical practice guideline was published online in the Journal of Clinical Oncology.

Can Cola Help Manage an Erlotinib-PPI Drug Interaction?

Can Cola Help Manage an Erlotinib-PPI Drug Interaction?

Taking erlotinib with cola resulted in a clinically relevant and statistically significant increase in erlotinib bioavailability during esomeprazole treatment, findings from a study published in the Journal of Clinical Oncology, showed.

Four Years on, What Has Been the Effect of the USPSTF's PSA Guidelines?

Four Years on, What Has Been the Effect of the USPSTF's PSA Guidelines?

The effect of the 2012 US Preventive Services Task Force (USPSTF) recommendations against prostate-specific antigen (PSA) screening for all men had a differential effect on urologists and primary care providers (PCPs)

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from myCME

Less PSA Testing in Primary Care, But Not UrologyExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

High-Fiber Diet Now May Lead to Lower Risk of Breast Cancer LaterExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Patients Stick With Self-Screening Kit for Colon CancerExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters